Rezaei, Farzin

N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study

Farokhnia, M., Azarkolah, A., Adinehfar, F., Khodaie-Ardakani, M.-R., Hosseini, S.-M.-R., Yekehtaz, H., Tabrizi, M., Rezaei, F., Salehi, B., Sadeghi, S.-M.-H., et al. (2013) · Clinical Neuropharmacology

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 155

Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.

Khodaie-Ardakani, M.-R., Mirshafiee, O., Farokhnia, M., Tajdini, M., Hosseini, S.-M.-R., Modabbernia, A., Rezaei, F., Salehi, B., Yekehtaz, H., Ashrafi, M., et al. (2014) · Psychiatry Research

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 104

Cognitive Behavior Therapy Targeting Intolerance of Uncertainty Versus Selective Serotonin Reuptake Inhibitor for Generalized Anxiety Disorder: A Randomized Clinical Trial

Zemestani, M., Beheshti, N., Rezaei, F., van der Heiden, C., & Kendall, P. C. (2021) · Behaviour Change

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychological Treatments and Assessments

Cited by 27

Changes in Neuroticism-Related Constructs Over the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Patients on an Optimal Dose of SSRI

Zemestani, M., Ommati, P., Rezaei, F., & Gallagher, M. W. (2022) · Personality Disorders: Theory, Research, and Treatment

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPersonality Disorders and Psychopathology

Cited by 26